Intervention Review

Hyperfractionated or accelerated radiotherapy for head and neck cancer

  1. Bertrand Baujat1,
  2. Jean Bourhis2,
  3. Pierre Blanchard3,
  4. Jens Overgaard4,
  5. Kian K Ang5,
  6. Michelle Saunders6,
  7. Aurélie Le Maître3,
  8. Jacques Bernier7,
  9. Jean Claude Horiot8,
  10. Emilie Maillard3,
  11. Thomas F Pajak9,
  12. Michael G Poulsen10,
  13. Abderrahmane Bourredjem3,
  14. Brian O'Sullivan11,
  15. Werner Dobrowsky12,
  16. Hliniak Andrzej13,
  17. Krzystof Skladowski14,
  18. John H Hay15,
  19. Luiz HJ Pinto16,
  20. Karen K Fu17,
  21. Carlo Fallai18,
  22. Richard Sylvester19,
  23. Jean Pierre Pignon20,*,
  24. MARCH Collaborative Group21

Editorial Group: Cochrane ENT Group

Published Online: 8 DEC 2010

Assessed as up-to-date: 7 AUG 2010

DOI: 10.1002/14651858.CD002026.pub2


How to Cite

Baujat B, Bourhis J, Blanchard P, Overgaard J, Ang KK, Saunders M, Le Maître A, Bernier J, Horiot JC, Maillard E, Pajak TF, Poulsen MG, Bourredjem A, O'Sullivan B, Dobrowsky W, Andrzej H, Skladowski K, Hay JH, Pinto LHJ, Fu KK, Fallai C, Sylvester R, Pignon JP, MARCH Collaborative Group. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD002026. DOI: 10.1002/14651858.CD002026.pub2.

Author Information

  1. 1

    Hôpital Tenon, Service ORL-CCF, Paris, France

  2. 2

    Institut Gustave Roussy, Département de Radiothérapie, Villejuif Cedex, France

  3. 3

    Institut Gustave Roussy, Biostatistics and Epidemiology Department, Villejuif Cedex, France

  4. 4

    Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark

  5. 5

    MD Anderson Cancer Center, Radiation Oncology Department, Houston, Texas, USA

  6. 6

    Marie Curie Research Wing for Oncology, Radiation Oncology Department, Northwood, Middlesex, UK

  7. 7

    Clinique de Genolia, Service de Radio-Oncologie, Genolier, Switzerland

  8. 8

    Clinique de Genolia, Service de Radio-Oncologie, Genolia, Switzerland

  9. 9

    RTOG, Statistical Headquarters, Philadelphia, PA, USA

  10. 10

    Mater Queensland Radium Institute, Brisbane, Australia

  11. 11

    Princess Margaret Hospital, Radiation Oncology Department, Toronto, ON, Canada

  12. 12

    Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne, UK

  13. 13

    (Deceased) Center for Oncology - M.SKL Curie, Warsaw, Poland

  14. 14

    Centrum Onkologii-Inst. M. Curie, Radiotherapy Clinic, Gliwice, Poland

  15. 15

    Vancouver Cancer Center, Department of Radiation Oncology, Vancouver, BC, Canada

  16. 16

    Instituto Nacional de Cancer, Departamento de Radioterapia, Rio de Janeiro, Brazil

  17. 17

    University of California San Francisco, San Mateo, CA, USA

  18. 18

    Instituto Nazionale dei Tumori, Dipartimento di Radiotherapia, Milano, Italy

  19. 19

    European Organisation for Research and Treatment of Cancer, Data Center, Brussels, Belgium

  20. 20

    Gustave Roussy Cancer Campus, Plateforme LNCC de Méta-analyse en Oncologie et Service de Biostatistique et d’Epidémiologie, Villejuif, France

  21. 21

    Villejuif Cedex, France

*Jean Pierre Pignon, Plateforme LNCC de Méta-analyse en Oncologie et Service de Biostatistique et d’Epidémiologie, Gustave Roussy Cancer Campus, Villejuif, France. jean-pierre.pignon@gustaveroussy.fr.

Publication History

  1. Publication Status: New
  2. Published Online: 8 DEC 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C.M.L. Driessen, J.P. de Boer, H. Gelderblom, C.R.N. Rasch, M.A. de Jong, B.M. Verbist, W.J.G. Melchers, M.E.T. Tesselaar, W.T.A. van der Graaf, J.H.A.M. Kaanders, C.M.L. van Herpen, Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study, European Journal of Cancer, 2016, 52, 77

    CrossRef

  2. 2
    Tejpal Gupta, Sadhana Kannan, Sarbani Ghosh–Laskar, Jai Prakash Agarwal, Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis, Head & Neck, 2015, 37, 5
  3. 3
    Björn Zackrisson, Elisabeth Kjellén, Karin Söderström, Eva Brun, Jan Nyman, Signe Friesland, Johan Reizenstein, Helena Sjödin, Lars Ekberg, Britta Lödén, Lars Franzén, Anders Ask, Gun Wickart-Johansson, Freddi Lewin, Thomas Björk-Eriksson, Erik Lundin, Tina Dalianis, Johan Wennerberg, Karl-Axel Johansson, Per Nilsson, Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – The ARTSCAN trial, Radiotherapy and Oncology, 2015, 117, 1, 99

    CrossRef

  4. 4
    Kamran A. Ahmed, Candace R. Correa, Thomas J. Dilling, Nikhil G. Rao, Ravi Shridhar, Andy M. Trotti, Richard B. Wilder, Jimmy J. Caudell, Altered Fractionation Schedules in Radiation Treatment: A Review, Seminars in Oncology, 2014, 41, 6, 730

    CrossRef

  5. 5
    Anna Merlotti, Daniela Alterio, Riccardo Vigna-Taglianti, Alessandro Muraglia, Luciana Lastrucci, Roberto Manzo, Giuseppina Gambaro, Orietta Caspiani, Francesco Miccichè, Francesco Deodato, Stefano Pergolizzi, Pierfrancesco Franco, Renzo Corvò, Elvio G Russi, Giuseppe Sanguineti, Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group, Radiation Oncology, 2014, 9, 1

    CrossRef

  6. 6
    G. Brandon Gunn, Steven J. Frank, Advances in Radiation Oncology for the Management of Oropharyngeal Tumors, Otolaryngologic Clinics of North America, 2013, 46, 4, 629

    CrossRef

  7. 7
    Alvin R. Cabrera, David S. Yoo, David M. Brizel, Contemporary Radiotherapy in Head and Neck Cancer, Surgical Oncology Clinics of North America, 2013, 22, 3, 579

    CrossRef

  8. 8
    Gary Mitchell, The Rationale for Fractionation in Radiotherapy, Clinical Journal of Oncology Nursing, 2013, 17, 4, 412

    CrossRef

  9. 9
    David J. Brenner, Exploring Two Two-Edged Swords, Radiation Research, 2012, 178, 1, 7

    CrossRef

  10. 10
    Farzan Siddiqui, Clement K. Gwede, Head and Neck Cancer in the Elderly Population, Seminars in Radiation Oncology, 2012, 22, 4, 321

    CrossRef

  11. 11
    Adrian C. Begg, Predicting Recurrence After Radiotherapy in Head and Neck Cancer, Seminars in Radiation Oncology, 2012, 22, 2, 108

    CrossRef

  12. 12
    David J. Brenner, Rainer K. Sachs, Lester J. Peters, H. Rodney Withers, Eric J. Hall, We Forget at Our Peril the Lessons Built into the α/β Model, International Journal of Radiation Oncology*Biology*Physics, 2012, 82, 4, 1312

    CrossRef

  13. 13
    David I PRYOR, Benjamin SOLOMON, Sandro V PORCEDDU, The emerging era of personalized therapy in squamous cell carcinoma of the head and neck, Asia-Pacific Journal of Clinical Oncology, 2011, 7, 3
  14. 14
    Sera Tort, How does altered fractionation radiotherapy affect outcomes in people with head and neck cancer?, Cochrane Clinical Answers,